NO20073368L - Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav - Google Patents

Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav

Info

Publication number
NO20073368L
NO20073368L NO20073368A NO20073368A NO20073368L NO 20073368 L NO20073368 L NO 20073368L NO 20073368 A NO20073368 A NO 20073368A NO 20073368 A NO20073368 A NO 20073368A NO 20073368 L NO20073368 L NO 20073368L
Authority
NO
Norway
Prior art keywords
gemcitabine
compositions
amide prodrug
amide
prodrug
Prior art date
Application number
NO20073368A
Other languages
English (en)
Inventor
David Michael Remick
David Michael Bender
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20073368L publication Critical patent/NO20073368L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

Foreliggende oppfinnelse nye amid promedikamenter av gemcitabin, sammensetninger av disse og fremgangsmåter for anvendelse.
NO20073368A 2004-12-17 2007-06-29 Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav NO20073368L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63742204P 2004-12-17 2004-12-17
PCT/US2005/043125 WO2006065525A1 (en) 2004-12-17 2005-11-30 Amide prodrug of gemcitabine, compositions and use thereof

Publications (1)

Publication Number Publication Date
NO20073368L true NO20073368L (no) 2007-07-16

Family

ID=36168678

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073368A NO20073368L (no) 2004-12-17 2007-06-29 Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav

Country Status (31)

Country Link
US (1) US7691827B2 (no)
EP (1) EP1831237B1 (no)
JP (1) JP5022911B2 (no)
KR (1) KR100874052B1 (no)
CN (1) CN101080417B (no)
AR (1) AR055009A1 (no)
AT (1) ATE405573T1 (no)
AU (1) AU2005316922B2 (no)
BR (1) BRPI0519117A2 (no)
CA (1) CA2589850C (no)
CY (1) CY1108447T1 (no)
DE (1) DE602005009255D1 (no)
DK (1) DK1831237T3 (no)
EA (1) EA011868B1 (no)
ES (1) ES2310860T3 (no)
HR (1) HRP20080529T3 (no)
IL (1) IL183666A (no)
MA (1) MA29154B1 (no)
MX (1) MX2007007228A (no)
MY (1) MY143677A (no)
NO (1) NO20073368L (no)
NZ (1) NZ554732A (no)
PE (1) PE20060771A1 (no)
PL (1) PL1831237T3 (no)
PT (1) PT1831237E (no)
RS (1) RS50629B (no)
SI (1) SI1831237T1 (no)
TW (1) TWI326687B (no)
UA (1) UA86119C2 (no)
WO (1) WO2006065525A1 (no)
ZA (1) ZA200705019B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2446092T3 (es) * 2006-06-21 2014-03-06 Eli Lilly And Company Formas cristalinas del profármaco amida gemcitabina, composiciones y uso de las mismas
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
US9447137B2 (en) 2012-11-07 2016-09-20 Nucorion Pharmaceuticals, Inc. Substituted gemcitabine aryl amide analogs
JP6420247B2 (ja) 2012-11-13 2018-11-07 ボーイエン セラピューティクス，インコーポレイティド ゲムシタビンプロドラッグ及びその使用
WO2015134334A1 (en) * 2014-03-03 2015-09-11 Suo Zucai Gemcitabine analogs
WO2016078160A1 (zh) * 2014-11-17 2016-05-26 常州方圆制药有限公司 胞苷衍生物及其应用
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
AU2019207626B2 (en) 2018-01-10 2023-10-05 Nucorion Pharmaceuticals, Inc. Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
KR20200118827A (ko) 2018-02-02 2020-10-16 마베릭스 온콜로지, 잉크. 젬시타빈 모노포스페이트의 소분자 약물 컨쥬게이트
WO2019204869A1 (en) 2018-04-26 2019-10-31 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
CN108864250A (zh) * 2018-05-29 2018-11-23 北京大学 一种FAPα酶敏感的吉西他滨前体药物及其制备方法和应用
SG11202100411TA (en) * 2018-08-03 2021-02-25 Cellix Bio Private Ltd Compositions and methods for the treatment of cancer
WO2021011692A1 (en) 2019-07-17 2021-01-21 Nucorion Pharmaceuticals, Inc. Cyclic deoxyribonucleotide compounds
WO2021216431A1 (en) 2020-04-21 2021-10-28 Ligand Pharmaceuticals, Inc. Benzyloxy phosph(on)ate compounds
EP4143199B1 (en) 2020-04-21 2025-11-19 Ligand Pharmaceuticals, Inc. Nucleotide prodrug compounds
PL249385B1 (pl) * 2022-11-23 2026-04-07 Narodowy Inst Onkologii Im Marii Sklodowskiej Curie Oddzial W Gliwicach Prolek-glikokoniugat pochodny gemcytabiny, jako związek o działaniu przeciwnowotworowym, sposób otrzymywania i zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
KR100483256B1 (ko) * 1997-01-24 2005-04-15 콘파마 아에스 젬시타빈 유도체
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
US7846436B2 (en) * 2003-11-28 2010-12-07 Chemgenes Corporation Oligonucleotides and related compounds

Also Published As

Publication number Publication date
EP1831237A1 (en) 2007-09-12
PL1831237T3 (pl) 2009-01-30
UA86119C2 (ru) 2009-03-25
WO2006065525A1 (en) 2006-06-22
KR20070086308A (ko) 2007-08-27
PT1831237E (pt) 2008-09-22
TW200634023A (en) 2006-10-01
US20090156547A1 (en) 2009-06-18
DK1831237T3 (da) 2008-10-27
CA2589850A1 (en) 2006-06-22
CY1108447T1 (el) 2014-04-09
JP2008524218A (ja) 2008-07-10
IL183666A (en) 2011-09-27
TWI326687B (en) 2010-07-01
MA29154B1 (fr) 2008-01-02
ZA200705019B (en) 2008-10-29
CA2589850C (en) 2012-05-01
AU2005316922A1 (en) 2006-06-22
EA011868B1 (ru) 2009-06-30
ES2310860T3 (es) 2009-01-16
PE20060771A1 (es) 2006-09-23
AU2005316922B2 (en) 2011-08-25
MX2007007228A (es) 2007-08-14
ATE405573T1 (de) 2008-09-15
NZ554732A (en) 2010-09-30
US7691827B2 (en) 2010-04-06
JP5022911B2 (ja) 2012-09-12
HK1109903A1 (en) 2008-06-27
BRPI0519117A2 (pt) 2008-12-23
MY143677A (en) 2011-06-30
EP1831237B1 (en) 2008-08-20
CN101080417A (zh) 2007-11-28
IL183666A0 (en) 2007-09-20
KR100874052B1 (ko) 2008-12-12
DE602005009255D1 (de) 2008-10-02
RS50629B (sr) 2010-06-30
AR055009A1 (es) 2007-08-01
HRP20080529T3 (en) 2008-12-31
SI1831237T1 (sl) 2009-02-28
EA200701300A1 (ru) 2007-10-26
CN101080417B (zh) 2011-01-19

Similar Documents

Publication Publication Date Title
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
CY1112402T1 (el) Ενισχυτες υποδοχεων γλουταμικου
CY1113314T1 (el) (3-αρυλ-πιπεραζιν-1-υλ) παραγωγα της 6,7-διαλκοξυκιναζολινης, 6,7-διαλκοξυφθαλαζινης και 6,7-διαλκοξυϊσοκινολινης
CY1111752T1 (el) Πυρρολοπυραζολες, δυναμικοι αναστολεις κινασης
EA200702048A1 (ru) Фармакокинетически улучшенные соединения
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
DK3530673T3 (da) Humaniserede anti-beta7-antagonister og anvendelser deraf
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
CY1109006T1 (el) Παραγωγα πουρινης ως αναστολεις κινασης
MX2010006736A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
TW200732349A (en) Anti-OX40L antibodies and methods using same
TW200640924A (en) VEGF-R2 inhibitors and methods
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ATE528989T1 (de) Kristalline feste rasagilin-base
TW200603798A (en) Disalt inhibitors of il-12 production
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
DK1761520T3 (da) Kinaseinhibitorer
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
TW200624426A (en) BACE inhibitors
GEP20125586B (en) Novel method for synthesis of (7-methoxy-l-naphthyl)-acetonitrile and application thereof in synthesis of agomelatine
TW200634023A (en) Amide prodrug of gemcitabine, compositions and use thereof
MX2008001538A (es) Aril piridinas y metodos para su uso.
UA85505C2 (en) Kinase inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application